Volunteer Botanicals Joins with Cultivate Tennessee in Effort to Regulate Hemp-Derived Cannabinoids
23 févr. 2023 09h08 HE
|
Volunteer Botanicals
MURFREESBORO, Tenn., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Volunteer Botanicals, which develops consistent, versatile hemp-based cannabinoid ingredients for use in a wide variety of consumer products,...
Volunteer Botanicals Launches Line of Wellness Products Created with Plant-based Ingredients
21 févr. 2023 07h00 HE
|
Volunteer Botanicals
MURFREESBORO, Tenn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Volunteer Botanicals, which develops consistent, versatile hemp-based cannabinoid ingredients for use in a wide variety of consumer products,...
Linnea SA Receives Swiss Narcotics License allowing for the Production and Exportation of High THC Active Pharmaceutical Ingredients
16 janv. 2023 05h00 HE
|
Linnea
RIAZZINO, Switzerland, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Linnea SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics...
Volunteer Botanicals’ Satival Cannabinoid Powders Demonstrate Potential in Clinical Study
10 janv. 2023 16h35 HE
|
Volunteer Botanicals
MURFREESBORO, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Volunteer Botanicals, which develops consistent, versatile hemp-based cannabinoid ingredients for use in a wide variety of consumer products,...
InMed Provides Business Update and Milestones for 2023
10 janv. 2023 07h30 HE
|
InMed Pharmaceuticals Inc.
Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023Progress preclinical research in glaucoma in preparation for human trialsAdvance research using rare cannabinoids in...
GPOPlus+ Assigned Exclusive Trademark License Agreement for the Creation of Yuengling’s Ice Cream Flavored CBD + Cannabinoid Products
12 déc. 2022 09h15 HE
|
GPO PLUS INC.
Las Vegas, NV and Atlanta, GA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- GPO Plus, Inc. (OTCQB: GPOX), a brand creation and distribution company focused on independent and regional retailers with an ever...
Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments
10 nov. 2022 16h00 HE
|
Dyadic International, Inc.
Received regulatory approval from South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 clinical trial to demonstrate clinical safety and antibody response in humans for...
KND Labs Earns NSF Certification
10 oct. 2022 12h30 HE
|
KND Labs
DENVER, Oct. 10, 2022 (GLOBE NEWSWIRE) -- KND Labs has been granted NSF certification, the company announced today. The NSF certification further commits KND Labs as the most compliant CBD...
SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility
26 sept. 2022 05h00 HE
|
SOMAÍ Pharmaceuticals
LISBON, Portugal, Sept. 26, 2022 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new state-of-the-art pharmaceutical EU-GMP facility in Portugal. SOMAÍ’s phase 1...
BioLife Sciences Inc. Expands Product Offerings in the Orthomolecular Medicine and Natural Health Markets with a Focus on Hemp Products
24 août 2022 08h00 HE
|
BioLife Sciences Inc.
HENDERSON, Nev., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (“BioLife” or the “Company”) (OTC: BLFE) announced today that it will be expanding the scope of its orthomolecular medicine...